Author

Jenny Hu

Observed names: J. Hu, Jenny C Hu, Jenny C. Hu, Jenny Chong Hu

Institutions: University of Southern California, AstraZeneca (United States)

Observed institutions: University of Southern California, Ford Motor Company (United States), City Of Hope National Medical Center, University of Minnesota, Amgen (United States), University of California, Los Angeles, Royal College of Art, Ronald Reagan UCLA Medical Center, UCLA Medical Center, University of Florida, Monash Health, AstraZeneca (United States), Beckman Research Institute, University of Nebraska Medical Center, University of Florida Health Science Center, Valencia College

OpenAlex ID: A5079826077

Cutaneous side effects of epidermal growth factor receptor inhibitors: Clinical presentation, pathogenesis, and management

2006 · Jenny C. Hu, Parrish Sadeghi, et al. · Journal of the American Academy of Dermatology · 229

Mammalian DNA2 helicase/nuclease cleaves G‐quadruplex DNA and is required for telomere integrity

2013 · Weiqiang Lin, Shilpa Sampathi, et al. · The EMBO Journal · 167

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention

2016 · Fabiana Rollini, Francesco Franchi, et al. · Journal of the American College of Cardiology · 126

PDF

Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

2016 · Francesco Franchi, Fabiana Rollini, et al. · Circulation · 97

Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines

2019 · Lauren D. Crow, Anokhi Jambusaria‐Pahlajani, et al. · Transplant International · 83

Life Cycle Energy Analysis for Automobiles

1995 · John L. Sullivan, Jenny Hu · SAE technical papers on CD-ROM/SAE technical paper series · 75

2017 White Paper on Recent Issues in Bioanalysis: A Global Perspective on Immunogenicity Guidelines & Biomarker Assay Performance (Part 3 – Lba: Immunogenicity, Biomarkers and PK Assays)

2017 · Shalini Gupta, Susan Richards, et al. · Bioanalysis · 69

PDF

Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor

2016 · Francesco Franchi, Gabriel Todd Faz, et al. · JACC: Cardiovascular Interventions · 40

Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine

2019 · Francesco Franchi, Fabiana Rollini, et al. · JACC: Cardiovascular Interventions · 36

PDF

Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation

2016 · Nicholas A. Kolaitis, Erin Duffy, et al. · Transplant International · 34

PDF

PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California

2020 · Gino K. In, Poorva Vaidya, et al. · Journal of Cancer Research and Clinical Oncology · 32

Comparison of cell-based and non-cell-based assay platforms for the detection of clinically relevant anti-drug neutralizing antibodies for immunogenicity assessment of therapeutic proteins

2015 · Jenny Hu, Iwona Wala, et al. · Journal of Immunological Methods · 32

Disparities in nonmelanoma skin cancer in Hispanic/Latino patients based on Mohs micrographic surgery defect size: A multicenter retrospective study

2021 · Laura Y. Blumenthal, Julia Arzeno, et al. · Journal of the American Academy of Dermatology · 26

Dermatology and HIV/AIDS in Africa

2011 · Noah Craft, Jenny Hu, et al. · Journal of Global Infectious Diseases · 26

Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and Target

2021 · Mark A. Kroenke, Troy E. Barger, et al. · Frontiers in Immunology · 25

A bioactive drug quantitation based approach for the detection of anti-drug neutralizing antibodies in human serum

2009 · Jenny Hu, Shalini Gupta, et al. · Journal of Immunological Methods · 22

Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma

2022 · Gino Kim In, Aparna Nallagangula, et al. · Journal for ImmunoTherapy of Cancer · 16

PDF

Interobserver reliability of teledermatology across all Fitzpatrick skin types

2016 · Lisa Altieri, Jenny Hu, et al. · Journal of Telemedicine and Telecare · 16

Mohs Versus Surgical Excision in Nonmelanoma Skin Cancers

2013 · Clifford T. Pereira, Erwin A. Kruger, et al. · Annals of Plastic Surgery · 13

Impact of timing from blood sampling to pharmacodynamic assessment on measures of platelet reactivity in patients treated with P2Y12 receptor inhibitors

2016 · Fabiana Rollini, Francesco Franchi, et al. · Thrombosis and Haemostasis · 9

Needs and Gaps in Resident Trainee Education, Clinical Patient Care, and Clinical Research in Cosmetic Dermatology: Position Statement of the Association of Academic Cosmetic Dermatology

2022 · Kira Minkis, Diana Bolotin, et al. · Archives of Dermatological Research · 8

PDF

Development of a Novel BAFF Responsive Cell Line Suitable for Detecting Bioactive BAFF and Neutralizing Antibodies against BAFF-Pathway Inhibiting Therapeutics

2014 · Jenny Hu, Yanbin Yu, et al. · Cells · 8

PDF

Pancreatic panniculitis after endoscopic retrograde cholangiopancreatography

2011 · Jenny C. Hu, Miguel A. Gutierrez · Journal of the American Academy of Dermatology · 7

Low Immunogenicity to Romiplostim in Clinical Studies with ITP Subjects.

2008 · Vibha Jawa, Martha Hokom, et al. · Blood · 6

Treatment Patterns and Outcomes in Patients with Advanced Biliary Tract Cancers Treated with Gemcitabine-Based Chemotherapy: A Retrospective Study

2025 · Farshid Dayyani, Heide A. Stirnadel-Farrant, et al. · Cancers · 5

PDF

Works count: 75

Citation count: 1,276

H-index: 16

I10-index: 19